Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Freedom from disease activity in multiple sclerosis.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Impaired Object Handling during Bimanual Task Performance in Multiple Sclerosis.
Multiple Sclerosis in Gulf War Era Veterans. 2. Military Deployment and Risk of Multiple Sclerosis in the First Gulf War.
Altered inter-subregion connectivity of the default mode network in relapsing remitting multiple sclerosis: a functional and structural connectivity study.
Contributing factors in multiple sclerosis and the female sex bias.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
Targeting NOX enzymes in the central nervous system: therapeutic opportunities.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
[Vitamin D tweets light to genes in multiple sclerosis].
Myelination of rodent hippocampal neurons in culture.
Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.

Pages